Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial.

Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Department of Dermatology, St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea. Department of Dermatology, Konkuk University School of Medicine, Seoul, South Korea. Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, South Korea. Department of Dermatology, Guro Hospital, College of Medicine, Korea University, Seoul, South Korea. Department of Dermatology, National Medical Center, Seoul, South Korea. Department of Dermatology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea. Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Department of Dermatology, Hallym University Sacred Heart Hospital, Anyang, South Korea.

Journal of the European Academy of Dermatology and Venereology : JEADV. 2017;(3):483-489

Abstract

BACKGROUND There is a lack of response data for topical treatments for psoriasis vulgaris in Asian patients. OBJECTIVES To determine the optimal maintenance regimen for topical treatment with calcipotriol monohydrate/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris, by comparing the efficacy of three 8-week maintenance regimens. METHODS This was a multicentre, prospective, randomized, controlled, parallel-group, open-label, phase 4 clinical trial, conducted in South Korea. Patients with psoriasis vulgaris on the limbs/trunk received once-daily treatment with calcipotriol monohydrate (50 μg/g)/betamethasone dipropionate (500 μg/g) gel for 8 weeks (induction phase). Responders (defined as an Investigator's Global Assessment of Disease Severity (IGA) grade of 'clear' or 'almost clear') were then randomized to receive 8 weeks' maintenance treatment with Xamiol® gel once daily as needed [pro re nata (PRN Group)], once daily every day (Continuous group), or twice weekly - on Saturday and Sunday (Weekend group). The primary endpoint was the percentage of IGA responders at week 16. RESULTS At the end of the induction phase, 62.18% of patients were IGA responders. At the end of the maintenance phase (week 16), the responder rate was 63.89% for the PRN group, 67.5% for the Continuous group and 31.43% for the Weekend group. The PRN and Continuous groups were statistically superior to the Weekend group (P = 0.0109 and P = 0.0015), but the PRN and Continuous groups did not differ statistically. The incidence of adverse events did not differ significantly between the groups. CONCLUSION Among Korean patients with psoriasis vulgaris, maintenance treatment with calcipotriol monohydrate/betamethasone dipropionate using a continuous daily regimen or an 'as needed' daily regimen provided similar efficacy, whereas a twice-weekly regimen was significantly less efficacious than either of these regimens.

Methodological quality

Metadata

MeSH terms : Psoriasis